论文部分内容阅读
近日,国家卫计委发布《关于延长脐带血造血干细胞库规划设置时间的通知》,目前北京、天津、上海等全国现有的7家公共库存储能力能够满足临床需求,因此在2020年前将不再新增脐带血库。同时,未来将筹建国家脐带血库。脐带血造血干细胞主要用于治疗白血病、再生障碍性贫血等血液系统疾病。脐带血造血干细胞库(以下简称脐带血库)是以脐带血造血干细胞移植为目的,具有采集、处理、保存和提供脐血干细胞能力的特殊血站。为规范脐带血库的管理,满足临床医疗服务需求,国家卫计委对脐带血库实行设置规划管理。根据设置规划,全国共批准设置了
Recently, the State Health Planning Commission released the Notice on Extending the Planning and Setting-up of Umbilical Cord Blood Hematopoietic Stem Cell Bank. At present, the existing public storage capacity of 7 public banks in Beijing, Tianjin and Shanghai can meet the clinical needs. Therefore, by 2020, No new cord blood bank. At the same time, the future will build a national cord blood bank. Umbilical cord blood hematopoietic stem cells are mainly used to treat blood diseases such as leukemia and aplastic anemia. Umbilical cord blood hematopoietic stem cell bank (hereinafter referred to as umbilical cord blood bank) is an umbilical cord blood hematopoietic stem cell transplantation for the purpose of collecting, processing, preservation and provision of umbilical cord blood stem cells in a special blood station. In order to regulate the management of umbilical cord blood banks and meet the demand of clinical medical services, the State Health Planning Commission implements the planning and management of umbilical cord blood banks. According to the set plan, a total of approved the establishment of the country